- Published on 03 February 2015
On February 2nd Amplifon announced the sale of the Amplifon Biomedica brand to GN Otometrics, the diagnostic division of the Danish Group GN ReSound.
The business sold to GN ReSound has 17 employees, sales of approximately Euro 4 million and negatively impacts the Amplifon Group’s Ebitda.
“Our Group intends to focus more and more on our core business, providing the best technologies and finest professionalism to those in need of hearing support in order to rediscover all the joy and fullness of living”, Franco Moscetti, Amplifon’s CEO commented. "We are, therefore, happy to transfer our biomedical business to a top tier international company that will know how to make the most of the expertise and quality service that we have always offered the medical community”.
“It is very encouraging that GN ReSound and Amplifon continue to find ways to take advantage of the strong relationship”, says Anders Hedegaard, CEO of GN Resound, “The acquisition of the Biomedica business suits very well into the Italian division of GN Otometrics and will enable us to offer innovative complete solutions to customers and achieve scale to drive the financial performance”.